LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AXA Diagnostics Highlights SkyLAB752 System

By LabMedica International staff writers
Posted on 05 Feb 2018
The SkyLAB752 system (Photo courtesy of AXA Diagnostics).
The SkyLAB752 system (Photo courtesy of AXA Diagnostics).
AXA Diagnostics (Milan, Italy) participated in MEDLAB Middle East, the world’s largest attended laboratory & IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE. AXA Diagnostics shared the booth with its sister company, Sclavo Diagnostics Int., where it provided all updates and new applications of its SkyLAB752 automated ELISA/IFA processor. Sclavo is a leading manufacturer of reagents for clinical chemistry, specific/urinary proteins, coagulation, and serology.
 
AXA Diagnostics is a partner to DASIT Group, which also comprises other leading IVD organizations, such as DASIT S.p.A. and industrial and research laboratories, such as CARLO ERBA Reagents S.r.l. and FASTER S.r.l. AXA Diagnostics develops, produces and markets IVD reagents dedicated to autoimmunity disease and instruments for the automation of all ELISA and IFA testing. The company also provides OEM equipment to fulfill the needs of automating the processing of IVD reagents.
 
The SkyLAB752 automated ELISA/IFA processor from AXA Diagnostics can simultaneously process ELISA microplates and IFA slides. The system is equipped with two innovative dispensing systems able to work simultaneously and independently. This enables the instrument to pipette an entire microplate in half the time compared to other analyzers available on the market. The movement of the manifold robotic arm does not interfere with the movement of the other two robotic arms, pipettes and microplate robotic arm, making the dispensing, washing and reading steps independent of each other. This architecture allows to maintain the execution times of each processing step aligned with the directions provided on the kit's IFU, leading to elimination of any drift effect.
 
Its innovative design allows constant access to the microplates by the washer and pipettes, even during incubation, so that the whole procedure applied to each strip can be closely followed and monitored. The SkyLAB 752 uses a LED microplate reading system that allows precision, reduced maintenance and a 3.3 OD photometric range. A state of the art LED light-source provides high performance and minimum maintenance, large measurement range and excellent reproducibility.
 
The system accommodates five positions on the working area equipped with incubators. Under the working area, two additional positions are available, one of them equipped with a shaker incubator. Each of the seven positions can contain both microplates and IFA slides. As an optional under the working area, SkyLAB 752 can accommodate from one to four positions equipped with incubators and shakers that can contain both microplates and IFA slides.
 
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more